News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
741,065 Results
Type
Article (46173)
Company Profile (339)
Press Release (694553)
Multimedia
Podcasts (68)
Webinars (12)
Section
Business (214313)
Career Advice (2205)
Deals (36805)
Drug Delivery (112)
Drug Development (87067)
Employer Resources (176)
FDA (16997)
Job Trends (15653)
News (364087)
Policy (34543)
Tag
Academia (2772)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (93)
Alliances (52871)
ALS (98)
Alzheimer's disease (1476)
Antibody-drug conjugate (ADC) (140)
Approvals (16975)
Artificial intelligence (287)
Autoimmune disease (24)
Automation (16)
Bankruptcy (374)
Best Places to Work (12226)
BIOSECURE Act (21)
Biosimilars (111)
Biotechnology (235)
Bladder cancer (82)
Brain cancer (31)
Breast cancer (291)
Cancer (2373)
Cardiovascular disease (189)
Career advice (1845)
Career pathing (31)
CAR-T (163)
Cell therapy (458)
Cervical cancer (20)
Clinical research (70768)
Collaboration (882)
Company closure (1)
Compensation (550)
Complete response letters (24)
COVID-19 (2773)
CRISPR (44)
C-suite (257)
Cystic fibrosis (105)
Data (2260)
Decentralized trials (2)
Denatured (25)
Depression (51)
Diabetes (282)
Diagnostics (6732)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (125)
Drug pricing (113)
Drug shortages (27)
Duchenne muscular dystrophy (97)
Earnings (88792)
Editorial (45)
Employer branding (21)
Employer resources (150)
Events (119040)
Executive appointments (763)
FDA (18307)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (791)
Gene editing (112)
Generative AI (25)
Gene therapy (331)
GLP-1 (781)
Government (4765)
Grass and pollen (6)
Guidances (67)
Healthcare (20161)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (133)
Indications (30)
Infectious disease (2927)
Inflammatory bowel disease (151)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (99)
Interviews (351)
IPO (17028)
IRA (44)
Job creations (3859)
Job search strategy (1567)
Kidney cancer (11)
Labor market (38)
Layoffs (516)
Leadership (19)
Legal (8238)
Liver cancer (77)
Lung cancer (339)
Lymphoma (157)
Machine learning (7)
Management (59)
Manufacturing (325)
MASH (72)
Medical device (14076)
Medtech (14081)
Mergers & acquisitions (20335)
Metabolic disorders (723)
Multiple sclerosis (85)
NASH (16)
Neurodegenerative disease (106)
Neuropsychiatric disorders (28)
Neuroscience (2055)
NextGen: Class of 2025 (7053)
Non-profit (4863)
Now hiring (39)
Obesity (386)
Opinion (243)
Ovarian cancer (76)
Pain (93)
Pancreatic cancer (84)
Parkinson's disease (157)
Partnered (22)
Patents (238)
Patient recruitment (115)
Peanut (51)
People (60709)
Pharmaceutical (77)
Pharmacy benefit managers (19)
Phase I (22183)
Phase II (31109)
Phase III (23151)
Pipeline (1238)
Policy (151)
Postmarket research (2793)
Preclinical (9264)
Press Release (70)
Prostate cancer (109)
Psychedelics (34)
Radiopharmaceuticals (265)
Rare diseases (412)
Real estate (6381)
Recruiting (66)
Regulatory (23776)
Reports (46)
Research institute (2535)
Resumes & cover letters (375)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (77)
Series A (137)
Series B (90)
Service/supplier (20)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (158)
Sponsored (34)
Startups (3829)
State (2)
Stomach cancer (15)
Supply chain (72)
Tariffs (42)
The Weekly (41)
Vaccines (756)
Venture capitalists (42)
Weight loss (258)
Women's health (38)
Worklife (18)
Date
Today (99)
Last 7 days (920)
Last 30 days (2735)
Last 365 days (34160)
2025 (11259)
2024 (36793)
2023 (41729)
2022 (53087)
2021 (57718)
2020 (56472)
2019 (49557)
2018 (37609)
2017 (34118)
2016 (33785)
2015 (39764)
2014 (33533)
2013 (28491)
2012 (30687)
2011 (31326)
2010 (29441)
Location
Africa (806)
Alabama (54)
Alaska (7)
Arizona (250)
Arkansas (14)
Asia (41429)
Australia (6999)
California (6289)
Canada (2048)
China (547)
Colorado (275)
Connecticut (290)
Delaware (155)
Europe (92067)
Florida (938)
Georgia (214)
Hawaii (1)
Idaho (63)
Illinois (580)
India (27)
Indiana (319)
Iowa (11)
Japan (163)
Kansas (108)
Kentucky (26)
Louisiana (12)
Maine (62)
Maryland (939)
Massachusetts (4766)
Michigan (226)
Minnesota (407)
Mississippi (2)
Missouri (85)
Montana (31)
Nebraska (25)
Nevada (65)
New Hampshire (68)
New Jersey (1761)
New Mexico (31)
New York (1803)
North Carolina (1085)
North Dakota (9)
Northern California (2725)
Ohio (215)
Oklahoma (15)
Oregon (39)
Pennsylvania (1409)
Puerto Rico (13)
Rhode Island (34)
South America (1185)
South Carolina (24)
South Dakota (1)
Southern California (2365)
Tennessee (104)
Texas (939)
United States (24032)
Utah (191)
Virginia (154)
Washington D.C. (67)
Washington State (573)
West Virginia (3)
Wisconsin (56)
741,065 Results for "frontage clinical services inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Frontage Laboratories and Medicover Integrated Clinical Services Announce Strategic Collaboration to Expand Global Genomic Testing Services
November 13, 2024
·
2 min read
Deals
Frontage Laboratories Inc. Acquires Frontage Clinical Services Inc.
Frontage Laboratories, Inc. completed the acquisition of Frontage Clinical Services Inc., a clinical Phase I-IIa business located in Secaucus, NJ. Frontage Clinical provides a complete suite of services from study design to the delivery of final reports.
August 2, 2022
·
2 min read
Deals
Frontage Acquires Nucro-Technics Inc. and Nucro-Technics Holdings, Inc.
Frontage Laboratories, Inc. and its wholly-owned subsidiary, Frontage Canada, Inc., completed the acquisition of Nucro-Technics Inc. and its affiliate Nucro-Technics Holdings, Inc.
August 16, 2023
·
3 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
Deals
Frontage Laboratories Acquires Accelera S.r.l.'s Bioanalytical and DMPK Businesses
Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera).
January 2, 2024
·
5 min read
Press Releases
BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
May 2, 2025
·
23 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
·
7 min read
Press Releases
Syncromune® Inc. to Present Clinical Data from SYNC-T Therapy SV-102 Phase 1 Trial at the American Society for Clinical Oncology Annual Meeting 2025
April 25, 2025
·
5 min read
Press Releases
RadNet, Inc. to Present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference March 17th, 2025
March 13, 2025
·
1 min read
IN PARTNERSHIP WITH DIA
Balancing Protection and Inclusion: The Evolution of Women in Clinical Trials
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses the evolution of women’s inclusion in clinical trials with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
March 27, 2025
·
1 min read
·
Lori Ellis
1 of 74,107
Next
